Skip to main content
Erschienen in: European Journal of Pediatrics 1/2022

05.08.2021 | Original Article

The effect of exchange transfusion on mortality in neonatal sepsis: a meta-analysis

verfasst von: Sitarah Mathias, Bharathi Balachander, Ashish Bosco, Carl Britto, Suman Rao

Erschienen in: European Journal of Pediatrics | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Although antimicrobials are the cornerstone of neonatal sepsis management, adjunctive therapies are required to improve outcomes. The aim of our study was to evaluate the effect of exchange transfusion (ET) on mortality (primary outcome) in neonatal sepsis, as well as on immunoglobulin, complement and neutrophil levels and assess its complications (secondary outcomes). Databases searched include PubMed, NCBI, Google Scholar, CINHAL, Ovid and Scopus. Randomized controlled trials (RCTs), controlled observational studies (COSs) and uncontrolled observational studies (UOSs) reporting mortality data from using ET in neonatal sepsis were included. Studies with additional interventions, non-septic ET indications and populations aged > 28 days were excluded. Data extracted include demographics, features of study, sepsis and ET, as well as mortality rates, immunological and laboratory changes and complications. Data was meta-analysed and displayed using forest plots. The meta-analysis of 14 studies (3 RCTs, 11 COSs) revealed a mortality benefit in septic neonates who underwent ET-RR 0.72 (CI 0.61–0.86, p = 0.01) and a significant increase in pooled immunological parameters (immunoglobulin, complement levels) (SMD 1.13, [0.25, 2.02], p = 0.02) and neutrophil levels (SMD 1.07 [0.04, 2.11], p = 0.03) compared to controls. The descriptive analysis of 9 UOSs revealed thrombocytopenia as the most frequently reported complication (n = 48). Moderate–high risk of bias was largely due to inadequate sample sizes and follow-up durations.
Conclusion: Currently, the use of ET in neonatal sepsis is not directly recommended due to low certainty of evidence, inadequate power and moderate–high risk of bias and heterogeneity.
Trial registration: PROSPERO (CRD42020176629) (https://​www.​crd.​york.​ac.​uk/​prospero/​display_​record.​php?​RecordID=​176629)
What is Known:
• Exchange transfusion is one of the adjunctive methods for treatment of neonatal sepsis.
What is New:
• The pooled analysis of all studies shows that exchange transfusion has a low certainty of evidence in the context of neonatal mortality. However, at this point, this intervention cannot be refuted or recommended due to heterogeneity of studies and inadequate power.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, et al 2009 The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 339. https://doi.org/10.1136/bmj.b2700 Liberati A, Altman DG, Tetzlaff J, et al 2009 The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 339. https://​doi.​org/​10.​1136/​bmj.​b2700
7.
Zurück zum Zitat McMaster University, Evidence Prime Inc (2015) GRADEpro GDT: GRADEpro Guideline Development Tool [Software] McMaster University, Evidence Prime Inc (2015) GRADEpro GDT: GRADEpro Guideline Development Tool [Software]
8.
Zurück zum Zitat Harrer M, Cuijpers P, Furukawa TA, Ebert DD (2019) Doing meta-analysis in R: a hands-on guide. PROTECT Lab Erlangen Harrer M, Cuijpers P, Furukawa TA, Ebert DD (2019) Doing meta-analysis in R: a hands-on guide. PROTECT Lab Erlangen
10.
Zurück zum Zitat Ac J, Hernán MA, Reeves BC, et al (2016) The risk of bias in non-randomized studies – of Interventions (ROBINS-I) assessment tool (version for cohort-type studies) ROBINS-I tool (stage I): at protocol stage ROBINS-I tool (stage II): For each study Specify a target randomized trial specif. 1–22 Ac J, Hernán MA, Reeves BC, et al (2016) The risk of bias in non-randomized studies – of Interventions (ROBINS-I) assessment tool (version for cohort-type studies) ROBINS-I tool (stage I): at protocol stage ROBINS-I tool (stage II): For each study Specify a target randomized trial specif. 1–22
11.
Zurück zum Zitat Pt J, Savović J, Page MJ, Sterne JAC (2019) Revised Cochrane risk-of-bias tool for randomized trials ( RoB 2 ) Pt J, Savović J, Page MJ, Sterne JAC (2019) Revised Cochrane risk-of-bias tool for randomized trials ( RoB 2 )
13.
Zurück zum Zitat Sadana S, Mathur NB, Thakur A (1997) Exchange transfusion in septic neonates with sclerema: effect on immunoglobulin and complement levels. Indian Pediatr 34:20–25PubMed Sadana S, Mathur NB, Thakur A (1997) Exchange transfusion in septic neonates with sclerema: effect on immunoglobulin and complement levels. Indian Pediatr 34:20–25PubMed
19.
Zurück zum Zitat Prod’hom LS, Choffat JM, Frenck N et al (1974) Care of the seriously ill neonate with hyaline membrane disease and with sepsis (sclerema neonatorum). Pediatrics 53:170–181CrossRef Prod’hom LS, Choffat JM, Frenck N et al (1974) Care of the seriously ill neonate with hyaline membrane disease and with sepsis (sclerema neonatorum). Pediatrics 53:170–181CrossRef
23.
Zurück zum Zitat Dalvi R, Rao S, Rangnekar J, Fernandez A (1991) Exchange transfusions in neonatal sepsis. Indian pediatrics 28:39–43PubMed Dalvi R, Rao S, Rangnekar J, Fernandez A (1991) Exchange transfusions in neonatal sepsis. Indian pediatrics 28:39–43PubMed
24.
Zurück zum Zitat De Curtis M, Vetrano G, Romano G et al (2020) Improvement tetrazolium ttransfusions immunizations of phagocytosis reduction in two after preterm and nitroblue with exchange infants septicemia. 829–830 De Curtis M, Vetrano G, Romano G et al (2020) Improvement tetrazolium ttransfusions immunizations of phagocytosis reduction in two after preterm and nitroblue with exchange infants septicemia. 829–830
26.
Zurück zum Zitat Vain NE, Mazlumian JR, Swarner OW, Cha CC (1980) Role of exchange transfusion in the treatment of severe septicemia. Pediatrics 66:693–697CrossRef Vain NE, Mazlumian JR, Swarner OW, Cha CC (1980) Role of exchange transfusion in the treatment of severe septicemia. Pediatrics 66:693–697CrossRef
27.
Zurück zum Zitat Bossi E, Meister B, Pfenninger J (1981) Exchange transfusion for severe neonatal septicemia. Pediatrics 67:941CrossRef Bossi E, Meister B, Pfenninger J (1981) Exchange transfusion for severe neonatal septicemia. Pediatrics 67:941CrossRef
29.
Zurück zum Zitat Hall R, Shigeoka A, Hill H (1983) Serum opsonic activity and peripheral neutrophil counts before and after exchange transfusion in infants with early onset group B streptococcal septicaemia. Pediatric Infectious Disease 2:356–358CrossRef Hall R, Shigeoka A, Hill H (1983) Serum opsonic activity and peripheral neutrophil counts before and after exchange transfusion in infants with early onset group B streptococcal septicaemia. Pediatric Infectious Disease 2:356–358CrossRef
30.
Zurück zum Zitat Courtney SSS, Hall RR, Harris DDDD (1979) Effect of blood-transfusions on mortality in early-onset group-b streptococcal septicemia. Lancet 462 Courtney SSS, Hall RR, Harris DDDD (1979) Effect of blood-transfusions on mortality in early-onset group-b streptococcal septicemia. Lancet 462
33.
Zurück zum Zitat Lemos L (1981) Exchange transfusion in treatment of sepsis. Pediatrics 68:471–472CrossRef Lemos L (1981) Exchange transfusion in treatment of sepsis. Pediatrics 68:471–472CrossRef
34.
Zurück zum Zitat Xanthou M, Mandyla H, Photopoulos S (1985) The use of exchange transfusions, immunoglobulins and granulocyte transfusions in neonatal sepsis. In: Ross Laboratories Special Conference Washington DC Xanthou M, Mandyla H, Photopoulos S (1985) The use of exchange transfusions, immunoglobulins and granulocyte transfusions in neonatal sepsis. In: Ross Laboratories Special Conference Washington DC
35.
Zurück zum Zitat Fleischmann-Struzek C, Goldfarb DM, Schlattmann P et al (2018) The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 6:223–230CrossRef Fleischmann-Struzek C, Goldfarb DM, Schlattmann P et al (2018) The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 6:223–230CrossRef
37.
Zurück zum Zitat Pelet B, Pediatrie S De, Hospitalier C, Vaudois U (1979) Exchange transfusion in newborn infants: Effects on granulocyte function. 687–690 Pelet B, Pediatrie S De, Hospitalier C, Vaudois U (1979) Exchange transfusion in newborn infants: Effects on granulocyte function. 687–690
39.
Zurück zum Zitat Jc J (2020) Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics Jc J (2020) Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics
44.
Zurück zum Zitat Monin P, Vert P, Andre M, Vibert M (1979) Transcutaneous PO2 monitoring (tcPO2) in the newborn during apneic spells, convulsions, cardiac catheterizations, and exchange transfusions. Birth Defects Orig Artic Ser 15:469–491PubMed Monin P, Vert P, Andre M, Vibert M (1979) Transcutaneous PO2 monitoring (tcPO2) in the newborn during apneic spells, convulsions, cardiac catheterizations, and exchange transfusions. Birth Defects Orig Artic Ser 15:469–491PubMed
Metadaten
Titel
The effect of exchange transfusion on mortality in neonatal sepsis: a meta-analysis
verfasst von
Sitarah Mathias
Bharathi Balachander
Ashish Bosco
Carl Britto
Suman Rao
Publikationsdatum
05.08.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 1/2022
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-021-04194-w

Weitere Artikel der Ausgabe 1/2022

European Journal of Pediatrics 1/2022 Zur Ausgabe

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

13.05.2024 Assistierte Reproduktion Nachrichten

Reproduktionsmedizinische Techniken haben theoretisch das Potenzial, den epigenetischen Code zu verändern und somit das Krebsrisiko der Kinder zu erhöhen. Zwischen Embryotransfer und Leukämie scheint sich ein solcher Zusammenhang bestätigt zu haben.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.